These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11890452)

  • 1. Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy.
    Manyak MJ; Ackerman SJ; Blute ML; Rein AL; Buesterien K; Sullivan EM; Tanio CP; Strauss MJ
    J Endourol; 2002 Feb; 16(1):51-6. PubMed ID: 11890452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part I-methods.
    Ackerman SJ; Rein AL; Blute M; Beusterien K; Sullivan EM; Tanio CP; Manyak MJ; Strauss MJ
    Urology; 2000 Dec; 56(6):972-80. PubMed ID: 11113743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II--results.
    Blute M; Ackerman SJ; Rein AL; Beusterien K; Sullivan EM; Tanio CP; Strauss MJ; Manyak MJ
    Urology; 2000 Dec; 56(6):981-7. PubMed ID: 11113744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term cost effectiveness of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    Pharmacoeconomics; 2006; 24(2):171-91. PubMed ID: 16460137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore.
    Chay J; Tung JYM; Su RJ; Aslim EJ; Wong C; Swan G; Chua WJ; Ho HSS; Finkelstein EA
    J Med Econ; 2023; 26(1):1269-1277. PubMed ID: 37800562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of feedback microwave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia.
    Kobelt G; Spångberg A; Mattiasson A
    BJU Int; 2004 Mar; 93(4):543-8. PubMed ID: 15008726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate.
    Nørby B; Nielsen HV; Frimodt-Møller PC
    Scand J Urol Nephrol; 2002; 36(4):286-95. PubMed ID: 12201922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement.
    Lourenco T; Armstrong N; N'Dow J; Nabi G; Deverill M; Pickard R; Vale L; MacLennan G; Fraser C; McClinton S; Wong S; Coutts A; Mowatt G; Grant A
    Health Technol Assess; 2008 Nov; 12(35):iii, ix-x, 1-146, 169-515. PubMed ID: 19032882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis.
    De La Rosette JJ; Floratos DL; Severens JL; Kiemeney LA; Debruyne FM; Pilar Laguna M
    BJU Int; 2003 Nov; 92(7):713-8. PubMed ID: 14616453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic evaluation of treatment for benign prostatic hyperplasia--transurethral resection vs thermotherapy vs laser vaporization].
    Aizawa T; Mamiya Y; Namiki K; Okubo Y; Kim T; Arai Y; Ito T; Miki M; Tachibana M
    Nihon Hinyokika Gakkai Zasshi; 2002 Nov; 93(7):736-42. PubMed ID: 12494518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy vs surgery as initial therapy for patients with moderate-to-severe benign prostate hyperplasia: a cost-effectiveness analysis.
    Erman A; Masucci L; Krahn MD; Elterman DS
    BJU Int; 2018 Nov; 122(5):879-888. PubMed ID: 30113127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Under what conditions is feedback microwave thermotherapy (ProstaLund Feedback Treatment) cost-effective in comparison with alpha-blockade in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms?
    Ragnarson Tennvall G; Hjelmgren J; Malmberg L
    Scand J Urol Nephrol; 2006; 40(6):495-505. PubMed ID: 17130102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of combination therapy for treatment of benign prostatic hyperplasia: a model based on the findings of the Combination of Avodart and Tamsulosin trial.
    Bjerklund Johansen TE; Baker TM; Black LK
    BJU Int; 2012 Mar; 109(5):731-8. PubMed ID: 21933326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transurethral resection versus minimally invasive treatments of benign prostatic hyperplasia: results of treatments. Our experience.
    Minardi D; Galosi AB; Yehia M; Cristalli A; Hanitzsch H; Polito M; Muzzonigro G
    Arch Ital Urol Androl; 2004 Mar; 76(1):11-8. PubMed ID: 15185816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral microwave thermotherapy: the gold standard for minimally invasive therapies for patients with benign prostatic hyperplasia?
    de la Rosette JJ; Laguna MP; Gravas S; de Wildt MJ
    J Endourol; 2003 May; 17(4):245-51. PubMed ID: 12816589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-effectiveness analysis of transurethral resection of the prostate and transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: two-year follow-up.
    Waldén M; Acosta S; Carlsson P; Pettersson S; Dahlstrand C
    Scand J Urol Nephrol; 1998 May; 32(3):204-10. PubMed ID: 9689700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonablative minimally invasive thermal therapies in the treatment of symptomatic benign prostatic hyperplasia.
    d'Ancona FC
    Curr Opin Urol; 2008 Jan; 18(1):21-7. PubMed ID: 18090485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.